RE: Ive decided its going to 2.15p at a warp speed29 Jun 2025 18:54
It can happen.
Johnson & Johnson recently made a major strategic bet on mental health, acquiring Intra-Cellular Therapies for $14.6 billion to access CAPLYTA, a novel CNS drug for depression and schizophrenia.
At that time, Intra-Cellular Therapies sold one drug treating schizophrenia and bipolar I and II depression, Caplyta, and had trials ongoing for others that could treat Alzheimer's Disease and Parkinson's Disease.